The company also hopes to generate additional annual revenue of between $10 million and $15 million from providing non-regulated wholesale products, and achieve annual operational cost savings of between $20 million and $30 million.
As a consequence of the reduced capital spend, Chorus will forgo annual growth revenue of between $100 million and $150 million through the six-year period that would have been generated by the investment.
"We are managing for cash - if there are investment opportunities where we can secure something like full cost recovery up front, then we'll look at those," said chief financial officer Andrew Carroll.
"In situations when managing for cash where payback is two or three years away, we just don't have that flexibility - it's a trade-off between value and cash." In its annual results yesterday, Chorus said it had decided not to pay an interim dividend. It withdrew dividend guidance late last year after the price cuts.
Chorus reported that its profit was down 7 per cent to $78 million for the six months to December 31.
The company's revenue was up 2 per cent to $535 million for the half year and earnings before interest, tax, depreciation and amortisation (ebitda) was down from $331 million to $329 million for six months.
Chorus shares closed down 1.5c yesterday at $1.42. Its share price has fallen by more than 50 per cent over the past year.
- additional reporting BusinessDesk